DUBLIN--(BUSINESS WIRE)-- Covidien plc (NYSE: COV) will report second-quarter results on April 21, 2011, before trading begins. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:
- At Covidien’s website: http://investor.covidien.com.
- By telephone: For both “listen-only” participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 800-591-6923. For participants outside the U.S., the dial-in number is 617-614-4907. The access code for all callers is 50679692.
- Through an audio replay: A replay of the conference call will be available beginning at 11:30 a.m. on April 21, 2011, and ending at 5:00 p.m. on April 28, 2011. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617-801-6888. The replay access code for all callers is 96784566.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2010 revenue of $10.4 billion, Covidien has approximately 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.
CONTACT:
Covidien
Eric Kraus, 508-261-8305
Senior Vice President
Corporate Communications
[email protected]
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
[email protected]
or
Bruce Farmer, 508-452-4372
Vice President
Public Relations
[email protected]
or
Todd Carpenter, 508-452-4363
Director
Investor Relations
[email protected]
KEYWORDS: United Kingdom United States Europe Asia Pacific North America Central America South America Canada Massachusetts Africa Ireland
INDUSTRY KEYWORDS: Health Biotechnology Medical Devices Pharmaceutical
MEDIA:
| Logo |